EE03850B1 - Budesoniidi peenestatud kristallilisi osakesi sisaldav ravimvorm - Google Patents

Budesoniidi peenestatud kristallilisi osakesi sisaldav ravimvorm

Info

Publication number
EE03850B1
EE03850B1 EEP199900533A EEP9900533A EE03850B1 EE 03850 B1 EE03850 B1 EE 03850B1 EE P199900533 A EEP199900533 A EE P199900533A EE P9900533 A EEP9900533 A EE P9900533A EE 03850 B1 EE03850 B1 EE 03850B1
Authority
EE
Estonia
Prior art keywords
budesonide
finely divided
pharmaceutical formulation
formulation containing
crystalline particles
Prior art date
Application number
EEP199900533A
Other languages
English (en)
Estonian (et)
Inventor
Bisrat Mikael
Moshashaee Saeed
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9900533A publication Critical patent/EE9900533A/xx
Publication of EE03850B1 publication Critical patent/EE03850B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP199900533A 1997-05-23 1998-05-15 Budesoniidi peenestatud kristallilisi osakesi sisaldav ravimvorm EE03850B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9701956A SE9701956D0 (sv) 1997-05-23 1997-05-23 New composition of matter
PCT/SE1998/000908 WO1998052544A1 (en) 1997-05-23 1998-05-15 Composition comprising finely divided, crystalline particles of budesonide

Publications (2)

Publication Number Publication Date
EE9900533A EE9900533A (et) 2000-06-15
EE03850B1 true EE03850B1 (et) 2002-10-15

Family

ID=20407079

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900533A EE03850B1 (et) 1997-05-23 1998-05-15 Budesoniidi peenestatud kristallilisi osakesi sisaldav ravimvorm

Country Status (28)

Country Link
US (2) US6346523B1 (sk)
EP (1) EP1005328B1 (sk)
JP (1) JP2001525850A (sk)
KR (1) KR100514971B1 (sk)
CN (1) CN1146406C (sk)
AR (1) AR015820A1 (sk)
AT (1) ATE246492T1 (sk)
AU (1) AU734763B2 (sk)
BR (1) BR9808812A (sk)
CA (1) CA2290538C (sk)
DE (1) DE69816997T2 (sk)
DK (1) DK1005328T3 (sk)
EE (1) EE03850B1 (sk)
ES (1) ES2205496T3 (sk)
HU (1) HUP0002212A3 (sk)
ID (1) ID24332A (sk)
IL (1) IL133098A (sk)
IS (1) IS5254A (sk)
NO (1) NO995540L (sk)
NZ (1) NZ500852A (sk)
PL (1) PL336902A1 (sk)
PT (1) PT1005328E (sk)
SE (1) SE9701956D0 (sk)
SK (1) SK158799A3 (sk)
TR (1) TR199902880T2 (sk)
TW (1) TW518236B (sk)
WO (1) WO1998052544A1 (sk)
ZA (1) ZA984127B (sk)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4990696A (en) * 1995-02-24 1996-09-11 Nanosystems L.L.C. Aerosols containing nanoparticle dispersions
AU3465901A (en) * 2000-03-03 2001-09-17 Boehringer Ingelheim Pharma Material processing by repeated solvent expansion-contraction
EP1354581A4 (en) * 2000-12-26 2007-07-04 Takeda Pharmaceutical POROUS SUBSTANCE AND METHOD FOR THE PRODUCTION THEREOF
GB0106403D0 (en) * 2001-03-15 2001-05-02 Pharmaceutical Profiles Labelling of dry powder formulations for inhalation
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US6746635B2 (en) 2001-08-08 2004-06-08 Brown University Research Foundation Methods for micronization of hydrophobic drugs
IL160931A0 (en) * 2001-10-10 2004-08-31 Boehringer Ingelheim Pharma Powder processing with pressurized gaseous fluids
US20030129242A1 (en) * 2002-01-04 2003-07-10 Bosch H. William Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
GB0216562D0 (en) * 2002-04-25 2002-08-28 Bradford Particle Design Ltd Particulate materials
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
WO2004105809A1 (en) 2003-05-22 2004-12-09 Elan Pharma International Ltd. Sterilization of dispersions of nanoparticulate active agents with gamma radiation
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20070020298A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
US20070020196A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension
ATE446581T1 (de) * 2004-03-12 2009-11-15 Trinity College Dublin Magnetoresistives medium
JP2008533055A (ja) * 2005-03-18 2008-08-21 ナノマテリアルズ テクノロジー ピーティーイー リミテッド 吸入剤
US8475845B2 (en) 2005-07-15 2013-07-02 Map Pharmaceuticals, Inc. Method of particle formation
EP1782839A1 (en) 2005-11-03 2007-05-09 Genetic S.p.A. Sterilization process of Glucocorticosteroid by supercritical CO2
US20070160542A1 (en) * 2005-12-20 2007-07-12 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070178049A1 (en) * 2005-12-20 2007-08-02 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070249572A1 (en) * 2005-12-20 2007-10-25 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070185066A1 (en) * 2005-12-20 2007-08-09 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070197486A1 (en) * 2005-12-20 2007-08-23 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids
US20070178051A1 (en) * 2006-01-27 2007-08-02 Elan Pharma International, Ltd. Sterilized nanoparticulate glucocorticosteroid formulations
EP1993598A2 (en) * 2006-02-15 2008-11-26 Tika Läkemedel AB Methods of manufacturing corticosteroid solutions
ES2691033T3 (es) 2007-02-11 2018-11-23 Map Pharmaceuticals Inc. Método de administración terapéutica de DHE para activar el alivio rápido de la migraña a la vez que se reduce al mínimo el perfil de los efectos secundarios
US20100294986A1 (en) * 2009-05-19 2010-11-25 Massachusetts Institute Of Technology Supercritical fluid facilitated particle formation in microfluidic systems
US20100298602A1 (en) * 2009-05-19 2010-11-25 Massachusetts Institute Of Technology Systems and methods for microfluidic crystallization
AU2011305566A1 (en) * 2010-09-22 2013-05-02 Map Pharmaceuticals, Inc. Aerosol composition for administering drugs
CN102975731B (zh) * 2012-04-24 2015-08-12 南车南京浦镇车辆有限公司 轨道车辆司机室骨架与车体的安装结构
WO2021219230A1 (en) 2020-04-30 2021-11-04 Paolo Fiorina Antiviral treatment
KR102567655B1 (ko) 2020-11-13 2023-08-17 주식회사 비츠로이엠 진공커패시터 및 진공커패시터 제조 방법
KR20230072023A (ko) 2021-11-17 2023-05-24 주식회사 비츠로이엠 가변형 진공 커패시터의 나선형 전극 위치 결정구조
KR20230072022A (ko) 2021-11-17 2023-05-24 주식회사 비츠로이엠 가변형 진공 커패시터

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1282405C (en) 1984-05-21 1991-04-02 Michael R. Violante Method for making uniformly sized particles from water-insoluble organic compounds
HU209603B (en) 1988-10-05 1994-09-28 Upjohn Co Process for production of solid powders in finalydivided microcristallin form
GB9001635D0 (en) 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
JP3282731B2 (ja) 1990-06-15 2002-05-20 メルク エンド カムパニー インコーポレーテッド 結晶の構造および大きさを改良する結晶化方法
SE9302777D0 (sv) 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
WO1993011773A1 (en) * 1991-12-18 1993-06-24 Aktiebolaget Astra New combination of formoterol and budesonide
GB9313642D0 (en) 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
SE9501384D0 (sv) 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles

Also Published As

Publication number Publication date
EP1005328B1 (en) 2003-08-06
CN1257424A (zh) 2000-06-21
AR015820A1 (es) 2001-05-30
CA2290538A1 (en) 1998-11-26
ES2205496T3 (es) 2004-05-01
DE69816997T2 (de) 2004-07-22
KR20010012821A (ko) 2001-02-26
ATE246492T1 (de) 2003-08-15
TR199902880T2 (xx) 2000-02-21
NO995540D0 (no) 1999-11-12
SK158799A3 (en) 2000-05-16
EP1005328A1 (en) 2000-06-07
EE9900533A (et) 2000-06-15
KR100514971B1 (ko) 2005-09-15
HUP0002212A2 (hu) 2000-12-28
DK1005328T3 (da) 2003-11-17
AU734763B2 (en) 2001-06-21
WO1998052544A1 (en) 1998-11-26
DE69816997D1 (de) 2003-09-11
HUP0002212A3 (en) 2001-04-28
PL336902A1 (en) 2000-07-17
US20020037257A1 (en) 2002-03-28
PT1005328E (pt) 2003-11-28
NO995540L (no) 1999-11-12
NZ500852A (en) 2001-07-27
SE9701956D0 (sv) 1997-05-23
US6468994B2 (en) 2002-10-22
BR9808812A (pt) 2000-07-18
IS5254A (is) 1999-11-18
AU7680098A (en) 1998-12-11
US6346523B1 (en) 2002-02-12
CN1146406C (zh) 2004-04-21
JP2001525850A (ja) 2001-12-11
IL133098A (en) 2005-03-20
TW518236B (en) 2003-01-21
CA2290538C (en) 2007-01-02
IL133098A0 (en) 2001-03-19
ZA984127B (en) 1998-11-23
ID24332A (id) 2000-07-13

Similar Documents

Publication Publication Date Title
EE03850B1 (et) Budesoniidi peenestatud kristallilisi osakesi sisaldav ravimvorm
NO990852L (no) Fremstilling av et finfordelt pulverformet karotenoidpreparat
HUP0003929A3 (en) Piperazine derivatives and their use for producing pharmaceutical compositions as anti-inflammatory agents and pharmaceutical compositions containing them
ZA985618B (en) Sulfonamide compounds and pharmaceutical use thereof
IT233201Y1 (it) Dispositivo a due componenti per la somministrazione di farmaci
HUP9900964A3 (en) Protease inhibitors and pharmaceutical compositions containing these compounds
HRP980260B1 (en) Pharmaceutical formulation of omeprazole
HUP0002209A3 (en) 4-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives and pharmaceutical compositions containing them
HUP0100949A3 (en) Aryl fused azapolycyclic compounds and pharmaceutical compositions containing the same
MA26507A1 (fr) Compositions pharmaceutiques d'aerosol
ZA962916B (en) New arylglycineamide derivatives processes for the manufacture thereof and pharmaceutical compositions containing these compounds
ZA974546B (en) Medicinal aerosol formulations of formoterol
AP9701160A0 (en) Compounds and pharmaceutical compositions containing them
IL117620A0 (en) Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same
ITMI921123A0 (it) Formulazioni farmaceutiche orali contenenti antocianosidi
IL116771A (en) 9-Substituted 2-(2-n-alkoxyphenyl) purin-6-one compounds their preparation and pharmaceutical compositions containing them
HUP0001858A3 (en) Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same and the use of the compounds
HUP0100102A3 (en) Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same
ZA984967B (en) Crystal modification of a pharmaceutical agent
HU9502426D0 (en) Compounds of pharmaceutical activity
DE69821978D1 (de) Mikronisierte bicyclische arzneistoffe enthaltende pharmazeutische zusammensetzungen
AU2080695A (en) Pharmaceutical inhalation compositions containing a solid active ingredient
DE69809928D1 (de) Tizoxanide und nitazoxanide enthaltende pharmazeutische zusammensetzungen
ITMI932014A0 (it) Composizioni farmaceutiche orali effervescenti contenenti estrone
NO20003393D0 (no) FremgangsmÕte for fremstilling av en farmasøytisk formulering

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

MM4A Lapsed by not paying the annual fees

Effective date: 20040515